Novartis AGNVSNYSE
Loading
Direct costs attributable to producing goods sold
3Y CAGR
+5.7%/yr
vs -5.5%/yr prior
5Y CAGR
-2.0%/yr
Recent acceleration
Acceleration
+11.2pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $13.69B | +6.7% |
| 2024 | $12.83B | +2.8% |
| 2023 | $12.47B | +7.7% |
| 2022 | $11.58B | -1.3% |
| 2021 | $11.73B | -22.4% |
| 2020 | $15.12B | +4.8% |
| 2019 | $14.43B | -0.6% |
| 2018 | $14.51B | +6.4% |
| 2017 | $13.63B | -22.2% |
| 2016 | $17.52B | - |